New Medical Laser Star MedTech Laser Group Is Born

New Medical Laser Star MedTech Laser Group is Born
MedWorld Advisors, an internationally recognized healthcare M&A advisory organization, is pleased to announce the formation of a new medical laser company, MedTech Laser Group, through the acquisition of shares in two similar companies.
MedTech Laser Group was born out of the successful acquisition of shares in A.R.C Laser GmbH in Nuremberg, Germany, and G.N.S. neoLaser Ltd. in Caesarea, Israel (adjacent to Tel Aviv), a strategic acquisition that was professionally guided and supported by Afinum Management GmbH in Munich, Germany. This strategic acquisition has been made under the professional guidance and full support of Afinum Management GmbH, Munich, Germany.
A.R.C. Laser is a privately owned, family-run company that has been involved in the field of medical laser technology since 1996 and is well known for its long history and its position as a pioneer in the industry. The company specializes in ophthalmic treatments, particularly glaucoma and cataract surgery, and its wide range of innovative laser technology solutions extends to a number of surgical applications in laryngology, otology, rhinology and veterinary medicine, demonstrating its strong R&D and product diversification capabilities.
On the other hand, neoLaser, founded in 2012, has rapidly emerged as a leader in laser systems and fiber optic technology in recent years, especially in the fields of endovenous laser ablation and anorectal medicine. Its cutting-edge laser solutions have not only strengthened its market leadership, but have also significantly revolutionized patient care and treatment outcomes.
Afinum is an independent investor active in small and medium-sized companies since 2000, focusing on four technology-driven verticals: Healthcare, Industrial Technology, Software & TMT, and Consumer & Internet.
With a culture of trust and collaboration, Afinum is committed to working with entrepreneurs to realize and unlock the maximum potential of their businesses. This transaction is not only Afinum 9 Fund's tenth platform investment, but also its third major deployment within the healthcare technology sector.
Under the shared vision of the founders of A.R.C. Laser and neoLaser, two leading companies have joined forces to create the MedTech Laser Group, in which Afinum has become the majority controlling shareholder, and the two founders have reinvested in the new entity, demonstrating their unwavering confidence in the future.
The MedTech Laser Group was formed based on the strategic insight that the global ophthalmic and surgical lasers market is experiencing unprecedented growth opportunities due to aging populations, increasing disease burdens, and breakthroughs in laser therapy technology, with the goal of keeping a finger on the pulse of the market and providing cutting-edge healthcare solutions.
Under the unified framework of MedTech Laser Group, A.R.C. Laser and neoLaser will work together to share market opportunities and accelerate revenue growth through synergies. While both companies will remain independent, they will strengthen in-depth cooperation in R&D, sales, marketing and regulatory affairs, and will work together to promote international expansion and deepen market penetration. In addition, the Group plans to further strengthen its market position through organic growth and strategic add-on acquisitions to enrich its technology and product portfolio.
MedWorld Advisors acted as the exclusive financial advisor on the transaction, successfully facilitating this unique collaboration across national boundaries and ensuring that both companies found the ideal partner to fuel their international expansion without compromising their respective cultures of integrity. The seller's role as a key strategic investor in the new group underscores its high level of recognition and anticipation of this partnership and its potential for future growth.